Verity Asset Management Inc. lowered its position in UnitedHealth Group Inc (NYSE:UNH) by 4.7% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 7,024 shares of the healthcare conglomerate’s stock after selling 348 shares during the quarter. UnitedHealth Group accounts for approximately 1.8% of Verity Asset Management Inc.’s investment portfolio, making the stock its 13th largest position. Verity Asset Management Inc.’s holdings in UnitedHealth Group were worth $1,869,000 at the end of the most recent quarter.

Several other institutional investors have also recently added to or reduced their stakes in UNH. FNY Investment Advisers LLC bought a new stake in UnitedHealth Group in the third quarter valued at approximately $106,000. Fort L.P. bought a new stake in UnitedHealth Group in the second quarter valued at approximately $119,000. Polaris Greystone Financial Group LLC bought a new stake in UnitedHealth Group in the third quarter valued at approximately $120,000. Columbia Asset Management bought a new stake in UnitedHealth Group in the third quarter valued at approximately $152,000. Finally, Pathstone Family Office LLC boosted its holdings in UnitedHealth Group by 1,430.8% in the third quarter. Pathstone Family Office LLC now owns 597 shares of the healthcare conglomerate’s stock valued at $160,000 after acquiring an additional 558 shares during the last quarter. 85.57% of the stock is owned by institutional investors.

Several brokerages recently commented on UNH. Zacks Investment Research cut UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, November 29th. Oppenheimer upped their target price on UnitedHealth Group from $295.00 to $300.00 and gave the company an “outperform” rating in a report on Wednesday, November 28th. Raymond James set a $310.00 target price on UnitedHealth Group and gave the company a “buy” rating in a report on Wednesday, November 28th. Bank of America upped their target price on UnitedHealth Group from $315.00 to $320.00 and gave the company a “buy” rating in a report on Wednesday, October 17th. Finally, Piper Jaffray Companies upped their target price on UnitedHealth Group to $312.00 and gave the company an “overweight” rating in a report on Wednesday, November 28th. Two investment analysts have rated the stock with a hold rating and twenty-one have issued a buy rating to the stock. UnitedHealth Group presently has an average rating of “Buy” and a consensus target price of $292.48.

In related news, Director Richard T. Burke sold 20,000 shares of the stock in a transaction on Wednesday, September 12th. The stock was sold at an average price of $263.41, for a total value of $5,268,200.00. Following the completion of the sale, the director now directly owns 1,720,112 shares of the company’s stock, valued at approximately $453,094,701.92. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Steven H. Nelson sold 8,142 shares of the stock in a transaction on Thursday, September 13th. The shares were sold at an average price of $265.00, for a total value of $2,157,630.00. Following the completion of the sale, the chief executive officer now directly owns 22,496 shares of the company’s stock, valued at $5,961,440. The disclosure for this sale can be found here. Over the last quarter, insiders sold 34,395 shares of company stock worth $9,186,302. 0.87% of the stock is owned by company insiders.

Shares of UNH opened at $276.85 on Friday. UnitedHealth Group Inc has a 12-month low of $208.48 and a 12-month high of $287.94. The company has a current ratio of 0.69, a quick ratio of 0.69 and a debt-to-equity ratio of 0.61. The firm has a market capitalization of $267.97 billion, a P/E ratio of 27.49, a PEG ratio of 1.60 and a beta of 0.76.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, October 16th. The healthcare conglomerate reported $3.41 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.30 by $0.11. UnitedHealth Group had a return on equity of 23.62% and a net margin of 5.71%. The company had revenue of $56.56 billion for the quarter, compared to analysts’ expectations of $56.34 billion. During the same period last year, the business earned $2.66 EPS. UnitedHealth Group’s quarterly revenue was up 12.4% compared to the same quarter last year. As a group, sell-side analysts forecast that UnitedHealth Group Inc will post 12.82 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Thursday, December 13th. Investors of record on Monday, December 3rd will be issued a $0.90 dividend. This represents a $3.60 dividend on an annualized basis and a dividend yield of 1.30%. The ex-dividend date is Friday, November 30th. UnitedHealth Group’s dividend payout ratio is currently 35.75%.

ILLEGAL ACTIVITY WARNING: “Verity Asset Management Inc. Sells 348 Shares of UnitedHealth Group Inc (UNH)” was first published by Watch List News and is owned by of Watch List News. If you are viewing this piece on another publication, it was stolen and reposted in violation of U.S. and international copyright and trademark laws. The original version of this piece can be viewed at https://www.watchlistnews.com/verity-asset-management-inc-sells-348-shares-of-unitedhealth-group-inc-unh/2668358.html.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

See Also: Swap

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.